In the group with ASM/W elevation, insulin resistance and liver function improved at follow-up compared with those at baseline with a decrease in HOMA-IR and ALT (both P < 0.001) although the liver function at baseline was worse in this group; however, no similar improvements were found in the group without ASM/W elevation (Fig. 2C and D). Here, GPT is linked to aggressive systemic mastocytosis.